QHP Capital

QHP Capital is a private equity firm that specializes in providing capital and partnering with management teams to build leading healthcare companies within the middle market. The firm focuses on tech-enabled life sciences and pharma service companies, aiming to reduce the total cost of care, fulfill unmet medical needs, diminish unnecessary procedures, improve efficiency, and elevate patient quality of life. QHP Capital works to transform these market leaders into larger, better positioned, and more valuable enterprises, leveraging a proprietary operational playbook and a strategic platform to source, diligence, and create value in growing healthcare businesses.

QHP Capital was formally established in 2021 as the management company for NovaQuest Private Equity. This formation built upon a long history of healthcare investing, with NovaQuest Private Equity itself being formalized in 2015. The roots of the firm trace back to NovaQuest Capital Management, which became an independent firm in 2010 after spinning out of Quintiles (now IQVIA), originally formed as a strategic investment arm within Quintiles Transnational in 2000. Quintiles was founded in 1982.

QHP Capital has made numerous investments and follow-on acquisitions across its portfolio. Notable platform investments include Azurity Pharmaceuticals, a dosage forms innovator; Catalyst Clinical Research, a full-service, technology-enabled, oncology-focused CRO; Core-Rx, a CDMO specializing in small market molecules; and Clinical Ink, a provider of eSource and patient engagement solutions. The firm has also announced investments in companies like Vector Clinical Trials and has been involved in significant transactions such as a $1.1 billion continuation vehicle for Azurity Pharmaceuticals.

Based in Raleigh, North Carolina, QHP Capital is led by an experienced team of investment, healthcare, strategy, and operations professionals. The team includes partners such as Vern Davenport, Jeff Edwards, Matt Jenkins, Ashton Poole, and Michael Sorensen, alongside a robust group of investment professionals, finance and operations staff, and strategic advisors. Their collective expertise in the healthcare sector and operational value creation is central to the firm's investment strategy.